Annotation Detail for SLCO1C1
Basic Information
TopGene Symbol: | SLCO1C1 ( OATP-F,OATP1,OATP14,OATP1C1,OATPF,OATPRP5,SLC21A14 ) |
---|
Gene Full Name: | solute carrier organic anion transporter family, member 1C1 |
---|
Band: | 12p12.2 |
---|
Quick Links | Entrez ID:53919; OMIM: 613389; Uniprot ID:SO1C1_HUMAN; ENSEMBL ID: ENSG00000139155; HGNC ID: 13819 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
| Transmembrane transport of small molecules |
Desease Name |
---|
height |
DEVELOPMENTAL |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLCO1C1 mRNA | affects expression | 16483693
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in decreased expression of SLCO1C1 mRNA | decreases expression | 15912405
|
C086401 |
pentabromodiphenyl ether |
pentabromodiphenyl ether results in increased expression of SLCO1C1 mRNA | increases expression | 18978342
|
C025299 |
polyphenols |
polyphenols results in decreased expression of SLCO1C1 mRNA | decreases expression | 16293270
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.19 | 18287403 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
2.72 | 16293270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
2.82 | 19370779 |
MESH:D007249 |
Inflammation |
|
polyphenols |
3.23 | 16366677 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
2.85 | 16698588 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.97 | 17997062 |
Pathway ID |
Pathway Name |
---|
REACT:15518 |
Transmembrane transport of small molecules |
PharmGKB Accession:PA37815
Releated gene ID |
Related gene Name |
PA37815 | SLCO1C1 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00252 |
inhibitor |
Dilantin W Phenobarbital 30mg Cap |
Anticonvulsants |
DB00279 |
inhibitor |
Thyrolar |
Hormone Replacement Agents |
DB00286 |
inhibitor |
Prempro |
Estrogens |
DB00390 |
substrate |
Digoxin |
Enzyme Inhibitors;Antiarrhythmic Agents;Cardiotonic Agents;Anti-Arrhythmia Agents |
DB00451 |
substrate |
Thyrolar |
Antithyroid Agents |
DB00563 |
substrate |
Methotrexate |
Antineoplastic Agents;Antirheumatic Agents;Antimetabolites;Enzyme Inhibitors;Folic Acid Antagonists;Dermatologic Agents;Immunosuppressive Agents;Nucleic Acid Synthesis Inhibitors;Abortifacient Agents, Nonsteroidal;Abortifacient Agents;Antimetabolites, Antineoplastic |
DB00586 |
inhibitor |
Diclofenac |
Cyclooxygenase Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
DB00917 |
substrate |
Dinoprostone |
Oxytocics;Prostaglandins |
DB00939 |
inhibitor |
Meclofenamic acid |
Cyclooxygenase Inhibitors |
DB01032 |
inhibitor |
Probenecid |
Uricosuric Agents;Adjuvants, Pharmaceutic |
DB01092 |
substrate |
Ouabain |
Enzyme Inhibitors;Cardiotonic Agents |
DB01583 |
inhibitor |
Liotrix |
Hormone Replacement Agents |
DB04348 |
inhibitor |
Taurocholic Acid |
Cholagogues and Choleretics;Detergents |